These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts. Mascitti M; Sartini D; Togni L; Pozzi V; Rubini C; Santarelli A; Emanuelli M Eur J Clin Invest; 2020 Apr; 50(4):e13220. PubMed ID: 32129473 [TBL] [Abstract][Full Text] [Related]
4. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma. Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696 [TBL] [Abstract][Full Text] [Related]
11. Nicotinamide N-methyltransferase protein expression in renal cell cancer. Zhang J; Xie XY; Yang SW; Wang J; He C J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases. Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625 [TBL] [Abstract][Full Text] [Related]
14. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer. Li J; Yue H; Yu H; Lu X; Xue X BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of oral mucosal melanoma: histopathological analysis in a retrospective cohort of 82 cases. Song H; Wu Y; Ren G; Guo W; Wang L Histopathology; 2015 Oct; 67(4):548-56. PubMed ID: 25809697 [TBL] [Abstract][Full Text] [Related]
16. Heparanase expression correlates with poor survival in oral mucosal melanoma. Wang X; Wen W; Wu H; Chen Y; Ren G; Guo W Med Oncol; 2013; 30(3):633. PubMed ID: 23794232 [TBL] [Abstract][Full Text] [Related]
17. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803 [TBL] [Abstract][Full Text] [Related]
18. Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts. Numakura S; Uozaki H Anticancer Res; 2024 Apr; 44(4):1653-1660. PubMed ID: 38537979 [TBL] [Abstract][Full Text] [Related]
19. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785 [TBL] [Abstract][Full Text] [Related]
20. Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity. Sartini D; Seta R; Pozzi V; Morganti S; Rubini C; Zizzi A; Tomasetti M; Santarelli L; Emanuelli M Biol Chem; 2015 Mar; 396(3):225-34. PubMed ID: 25204218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]